STOCK TITAN

Dolby Laboratories (DLB) Financials

DLB NYSE
FY2026 annual
Revenue $1.4B +5.3% YoY
Net Income $257.7M +1.1% YoY
EPS (Diluted) $2.70 +3.1% YoY
Free Cash Flow $359.9M -17.4% YoY
Market Cap $5.3B as of Nov 18, 2026
Price / Sales 3.7x on $1.4B revenue, FY2026
Price / Earnings 20.6x on $257.7M net income, FY2026
Price / Book 2.0x on $2.6B equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Sep 25, 2026 Reported Currency USD FYE September

Newest figures come from the 10-K for FY2026, filed Nov 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DLB SEC filings page.

Dolby Laboratories, Inc. (DLB) reported $1.4B in revenue for fiscal year 2026, up 5.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DLB FY2026

Dolby’s operating model is becoming more profitable, but FY2026 exposed a cash-conversion setback beneath that earnings improvement.

FY2026 operating income rose 14.7%, yet net income rose only 1.1%. That earnings improvement did not carry cleanly into cash: operating cash flow fell 15.4% and free cash flow fell 17.4%.

Gross margin compressed 1.3 percentage points as cost of revenue grew faster than sales, yet operating margin expanded 1.8 percentage points. The divergence suggests that operating-expense discipline or revenue mix cushioned weaker product-level economics.

FY2026 free cash flow was $359.9M, while share buybacks were $265M. Dividends added $136M, so distributions exceeded that year’s internally generated cash; liabilities were 17.5% of assets, indicating the payout was paired with a lightly burdened balance sheet.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 78 / 100
Financial Health Score 78/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Dolby Laboratories, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
85

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Dolby Laboratories, Inc. scores 85/100 on it among other operating companies.

Growth
51

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Dolby Laboratories, Inc. scores 51/100 on it among other operating companies.

Leverage
80

Dolby Laboratories, Inc. carried $0.21 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2026. With no long-term debt figure for fiscal year 2026, Dolby Laboratories, Inc. is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 80/100 among other operating companies measured the same way.

Liquidity
81

Dolby Laboratories, Inc. held $3.18 of current assets for every $1 of current liabilities at the end of fiscal year 2026, a current ratio of 3.18. Liquidity ranks operating companies on that ratio, and Dolby Laboratories, Inc. scores 81/100 among other operating companies.

Cash Flow
93

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Dolby Laboratories, Inc. scores 93/100 on it among other operating companies.

Returns
75

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Dolby Laboratories, Inc. scores 75/100 on it among other operating companies.

Altman Z-Score Safe
8.00

Dolby Laboratories, Inc. scores 8.00, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $5.3B against total liabilities of $556.0M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
7/8

Dolby Laboratories, Inc. passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed
1.55x

For every $1 of reported earnings, Dolby Laboratories, Inc. generates $1.55 in operating cash flow ($399.5M OCF vs $257.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$373.5M
YoY+21.7%
QoQ+22.5%
5Y CAGR+5.6%
10Y CAGR+4.8%

Dolby Laboratories, Inc. generated $373.5M in revenue in Q4 2026. This represents an increase of 21.7% from the same quarter a year earlier. Against the prior quarter it is up 22.5%.

EBITDA
$118.7M
YoY+129.8%
QoQ+108.6%
5Y CAGR+12.6%

Dolby Laboratories, Inc.'s EBITDA was $118.7M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 129.8% from the same quarter a year earlier. Against the prior quarter it is up 108.6%.

Net Income
$80.9M
YoY+64.0%
QoQ+182.8%
5Y CAGR+12.9%
10Y CAGR+13.0%

Dolby Laboratories, Inc. reported $80.9M in net income in Q4 2026. This represents an increase of 64.0% from the same quarter a year earlier. Against the prior quarter it is up 182.8%.

EPS (Diluted)
$0.86
YoY+68.6%
QoQ+186.7%
5Y CAGR+14.9%
10Y CAGR+14.1%

Dolby Laboratories, Inc. earned $0.86 per diluted share (EPS) in Q4 2026. This represents an increase of 68.6% from the same quarter a year earlier. Against the prior quarter it is up 186.7%.

Cash & Balance Sheet

Free Cash Flow
$73.8M
YoY-30.7%
QoQ-51.6%
5Y CAGR-5.5%
10Y CAGR+4.1%

Dolby Laboratories, Inc. generated $73.8M in free cash flow in Q4 2026, representing cash available after capex. This represents a decrease of 30.7% from the same quarter a year earlier. Against the prior quarter it is down 51.6%.

Cash & Debt
$622.9M
YoY-11.3%
QoQ-6.9%
5Y CAGR-12.7%
10Y CAGR+1.8%

Dolby Laboratories, Inc. held $622.9M in cash as of Q4 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$0.36
YoY+9.1%
QoQ0.0%
5Y CAGR+7.6%
10Y CAGR+9.9%

Dolby Laboratories, Inc. paid $0.36 per share in dividends in Q4 2026. This represents an increase of 9.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
93M
YoY-2.9%
QoQ-1.0%
5Y CAGR-1.7%
10Y CAGR-0.9%

Dolby Laboratories, Inc. had 93M shares outstanding in Q4 2026. This represents a decrease of 2.9% from the same quarter a year earlier. Against the prior quarter it is down 1.0%.

Margins & Returns

Gross Margin
84.4%
YoY-2.7pp
QoQ-2.4pp
5Y change-4.8pp
10Y change-2.6pp

Dolby Laboratories, Inc.'s gross margin was 84.4% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.4 percentage points.

Operating Margin
25.3%
YoY+15.6pp
QoQ+14.1pp
5Y change+11.2pp

Dolby Laboratories, Inc.'s operating margin was 25.3% in Q4 2026, reflecting core business profitability. This is up 15.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.1 percentage points.

Net Margin
21.7%
YoY+5.6pp
QoQ+12.3pp
5Y change+6.2pp
10Y change+11.4pp

Dolby Laboratories, Inc.'s net profit margin was 21.7% in Q4 2026, showing the share of revenue converted to profit. This is up 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.3 percentage points.

Return on Equity
3.1%
YoY+1.2pp
QoQ+2.0pp
5Y change+1.4pp
10Y change+1.9pp

Dolby Laboratories, Inc.'s quarterly ROE was 3.1% in Q4 2026: one quarter's net income over shareholder equity, not annualized. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.0 percentage points.

Capital Allocation

R&D Spending
$64.3M
YoY-4.7%
QoQ-2.2%
5Y CAGR+0.7%

Dolby Laboratories, Inc. invested $64.3M in research and development in Q4 2026. This represents a decrease of 4.7% from the same quarter a year earlier. Against the prior quarter it is down 2.2%.

Share Buybacks
$65.0M
YoY+85.7%
QoQ0.0%
5Y CAGR-7.5%
10Y CAGR+15.0%

Dolby Laboratories, Inc. spent $65.0M on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 85.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Capital Expenditures
$10.9M
YoY-32.6%
QoQ-27.0%
5Y CAGR-1.5%
10Y CAGR-7.4%

Dolby Laboratories, Inc. invested $10.9M in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 32.6% from the same quarter a year earlier. Against the prior quarter it is down 27.0%.

DLB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLB quarterly income statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Revenue$373.5M+21.7%$305.0M-3.3%$395.6M+7.1%$346.7M-2.9%$307.0M+0.7%$315.5M+9.3%$369.6M+1.4%$357.0M+13.1%
Cost of Revenue$58.2M+47.4%$40.3M-8.4%$44.7M+24.8%$43.2M+6.0%$39.5M+16.2%$44.0M+23.4%$35.8M-7.6%$40.8M+27.2%
Gross Profit$315.3M+17.9%$264.7M-2.5%$350.9M+5.1%$303.5M-4.0%$267.5M-1.2%$271.5M+7.3%$333.7M+2.4%$316.2M+11.5%
R&D Expenses$64.3M-4.7%$65.7M-0.4%$63.7M+3.2%$69.1M+3.7%$67.5M-1.7%$66.0M+0.7%$61.7M-1.3%$66.6M-0.6%
SG&A Expenses$157.0M-4.4%$160.7M+1.4%$172.1M+7.5%$161.8M-1.6%$164.2M+4.5%$158.5M+8.0%$160.0M+2.1%$164.5M+14.1%
Operating Income$94.6M+218.7%$34.3M-28.0%$112.9M+4.8%$62.2M-22.2%$29.7M-36.0%$47.6M+29.5%$107.8M-1.1%$79.9M+20.6%
EBITDA$118.7M+129.8%$56.9M-18.2%$137.0M+6.0%$86.3M-15.6%$51.7M-23.7%$69.6M+26.3%$129.3M+1.8%$102.2M+21.6%
Income Tax$21.1Mn/m$14.6M+62.6%$24.2M-13.5%$17.9M-0.3%-$8.0M-1020.0%$9.0M-14.6%$28.0M+19.1%$18.0M+35.7%
Net Income$80.9M+64.0%$28.6M-37.9%$94.9M+3.4%$53.3M-21.4%$49.3M-15.8%$46.1M+19.8%$91.8M-6.2%$67.8M+1.3%
EPS (Basic)$0.87+67.3%$0.30-37.5%$1.00+5.3%$0.56-21.1%$0.52-14.8%$0.48+20.0%$0.95-6.9%$0.71+1.4%
EPS (Diluted)$0.86+68.6%$0.30-37.5%$0.99+5.3%$0.55-21.4%$0.51-15.0%$0.48+20.0%$0.94-6.9%$0.70+1.4%
Diluted Shares (Avg)N/A95M-2.5%96M-2.0%97M-0.6%N/A97M-0.1%97M+0.6%97M-0.3%

Not reported in any period shown, so not listed: Interest Expense.

DLB Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLB quarterly balance sheet
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-Q
Total Assets$3.2B-1.8%$3.2B-1.2%$3.2B+0.6%$3.2B+1.1%$3.2B+3.8%$3.2B+7.5%$3.2B+6.1%$3.2B+7.6%
Current Assets$1.3B-4.3%$1.3B-0.9%$1.4B+1.8%$1.4B+9.5%$1.4B+16.2%$1.3B-8.9%$1.4B-10.5%$1.3B-11.4%
Cash & Equivalents$622.9M-11.3%$669.4M-4.2%$594.3M-5.2%$643.8M+23.6%$701.9M+45.6%$698.6M-5.8%$626.6M-11.7%$520.8M-20.7%
Short-Term Investments$500K-28.9%$652K-14.5%$460Kn/m$739Kn/m$703Kn/m$763K-99.4%$0-100.0%$0-100.0%
Inventory$28.5M-6.5%$30.8M-5.1%$31.9M-7.7%$31.3M-1.8%$30.4M-9.8%$32.4M-6.6%$34.6M-3.4%$31.8M-15.3%
Accounts Receivable$301.1M-9.1%$285.1M-4.2%$391.3M+24.6%$373.1M+10.0%$331.1M+5.0%$297.6M+4.1%$314.1M+11.3%$339.3M+15.7%
Long-Term Investments$89.4M+11.5%$86.4M+10.8%$81.2M+10.1%$85.0M-1.5%$80.2M-10.2%$78.0M-33.8%$73.8M-42.4%$86.3M-7.1%
Goodwill$529.1M-0.2%$528.3M-0.1%$529.7M+0.9%$530.3M+1.9%$529.9M-0.6%$528.8M+29.5%$525.0M+28.5%$520.4M+26.8%
Total Liabilities$556.0M-6.7%$563.9M-3.1%$622.4M-3.7%$589.3M-8.2%$595.8M-4.4%$581.8M+10.6%$646.0M+6.4%$641.6M+11.9%
Current Liabilities$417.8M-4.6%$416.3M+7.1%$474.6M+3.7%$443.5M+0.4%$437.8M+4.8%$388.8M+9.7%$457.5M+3.3%$441.9M+12.1%
Non-Current Liabilities$138.2M-12.5%$147.6M-23.5%$147.8M-21.6%$145.7M-27.0%$158.0M-23.0%$193.0M+12.4%$188.5M+14.9%$199.7M+11.5%
Total Equity$2.6B-0.7%$2.6B-0.8%$2.6B+1.7%$2.6B+3.4%$2.6B+5.9%$2.6B+7.1%$2.6B+6.3%$2.5B+6.9%
Retained Earnings$2.6B-0.7%$2.6B-0.7%$2.6B+1.1%$2.6B+2.4%$2.6B+5.6%$2.6B+6.3%$2.6B+6.2%$2.5B+7.4%

Not reported in any period shown, so not listed: Long-Term Debt.

DLB Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLB quarterly cash flow statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Operating Cash Flow$84.8M-31.0%$167.5M+147.4%$92.5M-47.1%$54.8M-48.7%$122.8M+5.7%$67.7M+218.3%$174.9M-3.6%$106.8M+1169.8%
Depreciation & Amortization$24.2M+9.8%$22.6M+3.1%$24.1M+11.9%$24.1M+8.0%$22.0M+3.0%$21.9M+19.8%$21.5M+19.5%$22.4M+25.1%
Stock-Based CompensationN/A$31.0M+0.8%$30.7M+0.1%$37.2M+3.2%N/A$30.7M+4.7%$30.7M+6.0%$36.1M+13.1%
Capital Expenditures$10.9M-32.6%$15.0M+133.2%$9.1M+31.4%$4.6M-31.7%$16.2M+120.1%$6.4M-15.6%$6.9M-22.6%$6.8M+11.1%
Free Cash Flow$73.8M-30.7%$152.5M+148.9%$83.4M-50.3%$50.2M-49.8%$106.6M-2.0%$61.3M+348.8%$168.0M-2.6%$100.0M+4229.0%
Investing Cash Flow-$29.6Mn/m-$9.8Mn/m-$46.1M-278.0%$1.2Mn/m-$21.9Mn/m-$6.4Mn/m$25.9Mn/m-$8.1M-1386.1%
Financing Cash Flow-$98.2Mn/m-$91.0Mn/m-$99.9Mn/m-$121.8Mn/m-$64.1Mn/m-$60.7Mn/m-$64.9Mn/m-$57.6Mn/m
Dividends Paid$33.7M+6.6%$34.0M+7.4%$34.3M+7.9%$34.3M+8.8%$31.6M+10.4%$31.6M+10.2%$31.8M+10.8%$31.5M+10.5%
Share Buybacks$65.0M+85.7%$65.0M-7.2%$65.0M+85.7%$70.0M+366.7%$35.0M+75.0%$70.0M+100.0%$35.0M+40.0%$15.0M-81.3%

DLB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DLB quarterly financial ratios
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Gross Margin84.4%-2.7pp86.8%+0.7pp88.7%-1.6pp87.5%-1.0pp87.1%-1.7pp86.1%-1.6pp90.3%+0.9pp88.6%-1.3pp
Operating Margin25.3%+15.6pp11.3%-3.8pp28.5%-0.6pp17.9%-4.5pp9.7%-5.5pp15.1%+2.4pp29.2%-0.7pp22.4%+1.4pp
Net Margin21.7%+5.6pp9.4%-5.2pp24.0%-0.9pp15.4%-3.6pp16.1%-3.1pp14.6%+1.3pp24.8%-2.0pp19.0%-2.2pp
Return on Equity3.1%+1.2pp1.1%-0.7pp3.6%+0.1pp2.1%-0.6pp1.9%-0.5pp1.8%+0.2pp3.6%-0.5pp2.7%-0.2pp
Return on Assets2.5%+1.0pp0.9%-0.5pp2.9%+0.1pp1.7%-0.5pp1.5%-0.4pp1.4%+0.1pp2.8%-0.4pp2.1%-0.1pp
Current Ratio3.180.0x3.19-0.3x2.98-0.1x3.17+0.3x3.17+0.3x3.44-0.7x3.04-0.5x2.91-0.8x
Liabilities-to-Equity0.210.0x0.220.0x0.240.0x0.230.0x0.230.0x0.220.0x0.250.0x0.260.0x
Asset Turnover0.120.0x0.100.0x0.120.0x0.110.0x0.100.0x0.100.0x0.110.0x0.110.0x
FCF Margin19.8%-15.0pp50.0%+30.6pp21.1%-24.4pp14.5%-13.5pp34.7%-1.0pp19.4%+14.7pp45.5%-1.9pp28.0%+27.3pp

Not reported in any period shown, so not listed: Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Dolby Laboratories, Inc. DLB FY2026 $1.4B $257.7M 18.1% $5.3B 78/100
Unifirst Corp UNF FY2026 $2.5B $109.5M 4.3% $4.4B 60/100
AZZ Inc. AZZ FY2026 $1.7B $317.3M 19.2% $3.8B 65/100
First Advantage Corporation FA FY2025 $1.6B -$34.8M -2.2% $3.7B 53/100
MAXIMUS, Inc. MMS FY2025 $5.4B $319.0M 5.9% $3.4B 57/100
ABM Industries, Inc. ABM FY2025 $8.7B $162.4M 1.9% $3.2B 43/100

Frequently Asked Questions

Dolby Laboratories, Inc. (DLB) reported $1.4B in total revenue for fiscal year 2026. This represents a 5.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Dolby Laboratories, Inc. (DLB) revenue grew by 5.3% year-over-year, from $1.3B to $1.4B in fiscal year 2026.

Yes, Dolby Laboratories, Inc. (DLB) reported a net income of $257.7M in fiscal year 2026, with a net profit margin of 18.1%.

Dolby Laboratories, Inc. (DLB) reported diluted earnings per share of $2.70 for fiscal year 2026. This represents a 3.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dolby Laboratories, Inc. (DLB) had EBITDA of $399.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Dolby Laboratories, Inc. (DLB) had a gross margin of 86.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Dolby Laboratories, Inc. (DLB) had an operating margin of 21.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Dolby Laboratories, Inc. (DLB) had a net profit margin of 18.1% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Yes, Dolby Laboratories, Inc. (DLB) paid $1.44 per share in dividends during fiscal year 2026.

Dolby Laboratories, Inc. (DLB) has a return on equity of 9.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Dolby Laboratories, Inc. (DLB) generated $359.9M in free cash flow during fiscal year 2026. This represents a -17.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Dolby Laboratories, Inc. (DLB) generated $399.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Dolby Laboratories, Inc. (DLB) had $3.2B in total assets as of fiscal year 2026, including both current and long-term assets.

Dolby Laboratories, Inc. (DLB) invested $39.6M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Dolby Laboratories, Inc. (DLB) invested $262.8M in research and development during fiscal year 2026.

Yes, Dolby Laboratories, Inc. (DLB) spent $265.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Dolby Laboratories, Inc. (DLB) had 93M shares outstanding as of fiscal year 2026.

Dolby Laboratories, Inc. (DLB) had a current ratio of 3.18 as of fiscal year 2026, which is generally considered healthy.

Dolby Laboratories, Inc. (DLB) had a liabilities-to-equity ratio of 0.21 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.

Dolby Laboratories, Inc. (DLB) had a return on assets of 8.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Dolby Laboratories, Inc. (DLB) trades at 20.6x earnings, its market capitalization divided by $257.7M net income, FY2026. The market capitalization is $5.3B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Dolby Laboratories, Inc. (DLB) trades at 3.7x sales, its market capitalization divided by $1.4B revenue, FY2026. The market capitalization is $5.3B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Dolby Laboratories, Inc. (DLB) has an Altman Z-Score of 8.00, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Dolby Laboratories, Inc. (DLB) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Dolby Laboratories, Inc. (DLB) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Dolby Laboratories, Inc. (DLB) scores 78 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top